1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Animal Parasiticides Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Animal Parasiticides Market Analysis and Forecasts, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Animal Parasiticides Used to Treat Animals
5.3. Disease Prevalence & Incidence Rate Globally With Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Animal Parasiticides Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2023–2031
6.3.1. Ectroparasiticides
6.3.1.1. Oral Tablets
6.3.1.2. Dips
6.3.1.3. Spray
6.3.1.4. Spot-on
6.3.1.5. Others
6.3.2. Endroparasiticides
6.3.2.1. Oral Suspension
6.3.2.2. Injectable
6.3.2.3. Feed Additives
6.3.2.4. Others
6.3.3. Endectocides
6.4. Market Attractiveness, by Product
7. Global Animal Parasiticides Market Analysis and Forecast, by Species
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Species, 2023–2031
7.3.1. Food-producing Animals
7.3.1.1. Cattle
7.3.1.2. Poultry
7.3.1.3. Swine
7.3.1.4. Others
7.3.2. Companion Animals
7.3.2.1. Dogs
7.3.2.2. Felines
7.3.2.3. Others
7.3.3. Other Livestock
7.4. Market Attractiveness, by Species
8. Global Animal Parasiticides Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Animal Parasiticides Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2023–2031
9.2.1. Ectroparasiticides
9.2.1.1. Oral Tablets
9.2.1.2. Dips
9.2.1.3. Spray
9.2.1.4. Spot-on
9.2.1.5. Others
9.2.2. Endroparasiticides
9.2.2.1. Oral Suspension
9.2.2.2. Injectable
9.2.2.3. Feed Additives
9.2.2.4. Others
9.2.3. Endectocides
9.3. Market Value Forecast, by Species, 2023–2031
9.3.1. Food-producing Animals
9.3.1.1. Cattle
9.3.1.2. Poultry
9.3.1.3. Swine
9.3.1.4. Others
9.3.2. Companion Animals
9.3.2.1. Dogs
9.3.2.2. Felines
9.3.2.3. Others
9.3.3. Other Livestock
9.4. Market Value Forecast, by Country, 2023–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Species
9.5.3. By Country
10. Europe Animal Parasiticides Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2023–2031
10.2.1. Ectroparasiticides
10.2.1.1. Oral Tablets
10.2.1.2. Dips
10.2.1.3. Spray
10.2.1.4. Spot-on
10.2.1.5. Others
10.2.2. Endroparasiticides
10.2.2.1. Oral Suspension
10.2.2.2. Injectable
10.2.2.3. Feed Additives
10.2.2.4. Others
10.2.3. Endectocides
10.3. Market Value Forecast, by Species, 2023–2031
10.3.1. Food-producing Animals
10.3.1.1. Cattle
10.3.1.2. Poultry
10.3.1.3. Swine
10.3.1.4. Others
10.3.2. Companion Animals
10.3.2.1. Dogs
10.3.2.2. Felines
10.3.2.3. Others
10.3.3. Other Livestock
10.4. Market Value Forecast, by Country/Sub-region, 2023–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Species
10.5.3. By Country/Sub-region
11. Asia Pacific Animal Parasiticides Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2023–2031
11.2.1. Ectroparasiticides
11.2.1.1. Oral Tablets
11.2.1.2. Dips
11.2.1.3. Spray
11.2.1.4. Spot-on
11.2.1.5. Others
11.2.2. Endroparasiticides
11.2.2.1. Oral Suspension
11.2.2.2. Injectable
11.2.2.3. Feed Additives
11.2.2.4. Others
11.2.3. Endectocides
11.3. Market Value Forecast, by Species, 2023–2031
11.3.1. Food-producing Animals
11.3.1.1. Cattle
11.3.1.2. Poultry
11.3.1.3. Swine
11.3.1.4. Others
11.3.2. Companion Animals
11.3.2.1. Dogs
11.3.2.2. Felines
11.3.2.3. Others
11.3.3. Other Livestock
11.4. Market Value Forecast, by Country/Sub-region, 2023–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Species
11.5.3. By Country/Sub-region
12. Latin America Animal Parasiticides Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2023–2031
12.2.1. Ectroparasiticides
12.2.1.1. Oral Tablets
12.2.1.2. Dips
12.2.1.3. Spray
12.2.1.4. Spot-on
12.2.1.5. Others
12.2.2. Endroparasiticides
12.2.2.1. Oral Suspension
12.2.2.2. Injectable
12.2.2.3. Feed Additives
12.2.2.4. Others
12.2.3. Endectocides
12.3. Market Value Forecast, by Species, 2023–2031
12.3.1. Food-producing Animals
12.3.1.1. Cattle
12.3.1.2. Poultry
12.3.1.3. Swine
12.3.1.4. Others
12.3.2. Companion Animals
12.3.2.1. Dogs
12.3.2.2. Felines
12.3.2.3. Others
12.3.3. Other Livestock
12.4. Market Value Forecast, by Country/Sub-region, 2023–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Species
12.5.3. By Country/Sub-region
13. Middle East & Africa Animal Parasiticides Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2023–2031
13.2.1. Ectroparasiticides
13.2.1.1. Oral Tablets
13.2.1.2. Dips
13.2.1.3. Spray
13.2.1.4. Spot-on
13.2.1.5. Others
13.2.2. Endroparasiticides
13.2.2.1. Oral Suspension
13.2.2.2. Injectable
13.2.2.3. Feed Additives
13.2.2.4. Others
13.2.3. Endectocides
13.3. Market Value Forecast, by Species, 2023–2031
13.3.1. Food-producing Animals
13.3.1.1. Cattle
13.3.1.2. Poultry
13.3.1.3. Swine
13.3.1.4. Others
13.3.2. Companion Animals
13.3.2.1. Dogs
13.3.2.2. Felines
13.3.2.3. Others
13.3.3. Other Livestock
13.4. Market Value Forecast, by Country/Sub-region, 2023–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Species
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Bayer AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Bimeda Animal Health
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Boehringer Ingelheim GmbH
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Ceva Sante Animale
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Elanco (Eli Lilly and Company)
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Merck & Co., Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Vetoquinol
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Zoetis, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Virbac
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. The Chanelle Group
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Sunmitomo Chemical Co., Ltd.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/